Furthermore, in murine neuroblastoma cells transfected with the human APP mutant, EGCG inhibited the generation of Aβ1–40 and Aβ1–42 by increasing the action of α-secretase, which promotes the non-amyloidogenic processing of APP (Rezai-Zadeh et al., 2005). The gene discussed is APP; the disease is neuroblastoma.